Financial Performance - Total Revenue for Q4 2024 was $74.0 million, a decrease of 17.0% compared to $89.2 million in Q4 2023[7] - Billings for Q4 2024 were $116.3 million, a decrease of 11.9% compared to $131.9 million in Q4 2023[7] - Adjusted EBITDA for Q4 2024 was $6.4 million, a decrease of $3.6 million compared to $10.0 million in Q4 2023[7] - Net Loss for Q4 2024 was $(15.6) million, significantly improved from a Net Loss of $(100.8) million in Q4 2023[7] - For the full year 2024, Total Revenue was $278.3 million, a decrease of 10.0% compared to $309.2 million in 2023[7] - Net loss for the year ended December 31, 2024, was $189,304,000, compared to a net loss of $134,702,000 in 2023, representing a 40.5% increase in losses[27] - Total revenue for the year ended December 31, 2024, was $278.3 million, down from $309.2 million in 2023, reflecting a decrease of about 10%[33] - Adjusted EBITDA for the year ended December 31, 2024, was $2.5 million, a decline from $3.8 million in 2023[36] - The company reported free cash flow of $(28.1) million for the year ended December 31, 2024, compared to $(12.6) million in 2023, indicating a worsening cash flow situation[40] User Metrics - Cardlytics MAUs in Q4 2024 were 167.3 million, a slight decrease of 0.4% compared to 168.0 million in Q4 2023[11] - Cardlytics ARPU for Q4 2024 was $0.44, a decrease of 16.7% compared to $0.53 in Q4 2023[11] - Monthly Active Users (MAUs) and Average Revenue Per User (ARPU) metrics were highlighted as key performance indicators, although specific figures were not disclosed[19][23] Guidance and Expectations - The company anticipates Q1 2025 Billings to be in the range of $91.5 - $94.5 million, representing a year-over-year decline of 10% to 13%[13] - Adjusted Contribution for Q1 2025 is expected to be between $30.0 - $32.5 million, a decrease of 14% to 19% year-over-year[13] - The company aims to deliver sequential improvements and positive Adjusted EBITDA in 2025[4] - For Q1 2025, Cardlytics provided guidance for revenue between $57.0 million and $60.0 million, with billings expected to be between $91.5 million and $94.5 million[43] Asset and Liability Changes - Total assets decreased from $574,144,000 in 2023 to $392,711,000 in 2024, reflecting a decline of approximately 31.6%[25] - Total liabilities decreased from $439,346,000 in 2023 to $322,718,000 in 2024, a reduction of approximately 26.5%[25] - Cash and cash equivalents decreased from $91,830,000 in 2023 to $65,594,000 in 2024, a decline of approximately 28.6%[25] - Cash, cash equivalents, and restricted cash decreased to $65.6 million at the end of 2024 from $91.8 million at the end of 2023, a decline of approximately 28.5%[31] - The net cash used in operating activities for the year ended December 31, 2024, was $(8.8) million, compared to $(0.2) million in 2023[31] Expenses and Impairments - Partner Share and other third-party costs for Q4 2024 were $33,285,000, down from $41,880,000 in Q4 2023, indicating a reduction of about 20.7%[27] - Stock-based compensation expense totaled $8,673,000 for Q4 2024, compared to $11,024,000 in Q4 2023, a decrease of approximately 21.4%[29] - The company reported a significant impairment of goodwill and intangible assets amounting to $131,595,000 for the year 2024[27] - The company incurred an impairment of goodwill and intangible assets amounting to $131.6 million for the year ended December 31, 2024, compared to $70.5 million in 2023[36] - The company reported stock-based compensation expense of $40.4 million for the year ended December 31, 2024, slightly down from $41.0 million in 2023[36] Consumer Incentives - Consumer incentives for the year ended December 31, 2024, increased to $165.5 million from $144.2 million in 2023, marking a growth of approximately 14.5%[33]

Core Viewpoint - A class action securities lawsuit has been filed against Cardlytics, Inc. for alleged securities fraud affecting investors between March 14, 2024, and August 7, 2024 [1][2]. Group 1: Allegations and Claims - The lawsuit claims that the defendants made false statements regarding consumer engagement and its impact on revenue, indicating that increased consumer engagement led to higher consumer incentives but did not result in proportional billings [2]. - It is alleged that there was a significant risk of slowing or declining revenue growth due to the inability to increase billings in line with consumer engagement [2]. - The changes to the Ads Decision Engine, which were intended to boost consumer engagement, resulted in "under-delivery" of budgets and customer billing estimates, misleading investors about the company's operational health [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until March 25, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees, emphasizing that there is no financial obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cardlytics, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions during a specified class period [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from March 14, 2024, to August 7, 2024 [2]. - Allegations include that the company failed to disclose that increased consumer engagement led to higher consumer incentives, and that it could not increase billings in line with this engagement [2]. - There is a significant risk that revenue growth may slow or decline due to these factors, and the changes to the Ads Decision Engine resulted in "under-delivery" of budgets and customer billing estimates [2]. Group 2: Shareholder Actions - Shareholders are encouraged to register for the class action by March 25, 2025, to potentially be appointed as lead plaintiffs [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [3]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Viewpoint - A class action securities lawsuit has been filed against Cardlytics, Inc. for alleged securities fraud affecting investors between March 14, 2024, and August 7, 2024 [1][2] Group 1: Allegations and Claims - The lawsuit claims that the defendants made false statements regarding the impact of increasing consumer engagement, which led to higher consumer incentives [2] - It is alleged that the Company was unable to increase its billings in line with the increased consumer engagement, posing a risk of slowing or declining revenue growth [2] - The changes to the Ads Decision Engine, which were intended to boost consumer engagement, resulted in "under-delivery" of budgets and customer billing estimates [2] - As a consequence of these issues, the defendants' positive statements about the Company's business and prospects were misleading and lacked a reasonable basis [2] Group 2: Next Steps for Investors - Investors who suffered losses in Cardlytics during the specified timeframe have until March 25, 2025, to request appointment as lead plaintiff [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4]

Core Viewpoint - A class action securities lawsuit has been filed against Cardlytics, Inc. for alleged securities fraud affecting investors between March 14, 2024, and August 7, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Cardlytics made false statements regarding consumer engagement and its ability to increase billings, leading to a significant risk of revenue growth slowing or declining [2]. - It is alleged that changes to the Ads Decision Engine resulted in "under-delivery" of budgets and customer billing estimates, which misled investors about the company's business prospects [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until March 25, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cardlytics, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions during a specified class period [1][2]. Allegations - The complaint alleges that during the class period from March 14, 2024, to August 7, 2024, the defendants made materially false and/or misleading statements [1]. - Key allegations include: - Increasing consumer engagement led to an increase in consumer incentives [1]. - The company was unable to increase its billings in line with the increased consumer engagement [1]. - There was a significant risk that revenue growth would slow or decline as a result [1]. - Changes to the Ads Decision Engine resulted in "under-delivery" of budgets and customer billing estimates [1]. - Defendants' positive statements about the company's business and prospects were materially misleading and lacked a reasonable basis [1]. Next Steps for Shareholders - Shareholders who purchased shares of CDLX during the specified timeframe are encouraged to register for the class action by March 25, 2025 [2]. - Registration allows shareholders to be enrolled in a portfolio monitoring software for status updates throughout the case [2]. Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm is committed to ensuring companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [3].

Core Viewpoint - A class action securities lawsuit has been filed against Cardlytics, Inc. for alleged securities fraud affecting investors between March 14, 2024, and August 7, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Cardlytics made false statements regarding consumer engagement and its ability to increase billings, leading to a significant risk of revenue growth slowing or declining [2]. - It is alleged that changes to the Ads Decision Engine resulted in "under-delivery" of budgets and customer billing estimates, which misled investors about the company's business prospects [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until March 25, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cardlytics, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions during a specified class period [1]. Group 1: Allegations - The complaint alleges that during the class period from March 14, 2024, to August 7, 2024, Cardlytics made materially false and/or misleading statements [1]. - Specific allegations include that increasing consumer engagement led to higher consumer incentives, but the company could not increase its billings accordingly, posing a risk of revenue growth slowing or declining [1]. - Changes to the Ads Decision Engine resulted in increased consumer engagement but also led to "under-delivery" of budgets and customer billing estimates, making the company's positive statements misleading [1]. Group 2: Class Action Details - Shareholders who purchased shares of CDLX during the class period are encouraged to register for the class action, with a deadline of March 25, 2025, to seek lead plaintiff status [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Core Viewpoint - Cardlytics is facing a class-action lawsuit for allegedly misleading investors about its growth prospects, with claims that the company failed to disclose critical information regarding its financial performance and business operations [1][3][4]. Group 1: Lawsuit Details - The class period for the lawsuit is from March 14, 2024, to August 7, 2024, with a lead plaintiff deadline set for March 25, 2025 [2]. - The lawsuit, filed in the Northern District of Georgia, accuses Cardlytics and certain executives of violating the Securities Exchange Act of 1934 [2]. - Plaintiffs allege that Cardlytics made false and misleading statements regarding the impact of increased consumer engagement on financial performance, claiming that while engagement rose, it did not translate into corresponding growth in billings [4]. Group 2: Financial Performance and Stock Impact - Following the company's disclosures, two significant stock drops occurred: on May 8, 2024, after reporting only an 8% year-over-year revenue increase despite a 12% increase in billings, leading to a stock price drop of over 36% [6]. - On August 7, 2024, Cardlytics reported a 9% year-over-year decline in revenue to $69.6 million and a 3% decrease in adjusted contribution to $36.4 million, resulting in a stock price plummet of over 57% after the announcement of the CEO's resignation [7].

Core Viewpoint - A class action securities lawsuit has been filed against Cardlytics, Inc. for alleged securities fraud affecting investors between March 14, 2024, and August 7, 2024 [1][2]. Group 1: Allegations and Claims - The lawsuit claims that the defendants made false statements regarding consumer engagement and its impact on revenue, indicating that increased consumer engagement led to higher consumer incentives but did not result in proportional billings [2]. - It is alleged that there was a significant risk of slowing or declining revenue growth due to the inability to increase billings in line with consumer engagement [2]. - The changes to the Ads Decision Engine, which were intended to boost consumer engagement, resulted in "under-delivery" of budgets and customer billing estimates, misleading investors about the company's operational health [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until March 25, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees, emphasizing that there is no financial obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the U.S. [4].